The challenge of developing universal vaccines

F1000 Medicine Reports

Volumn 3, Issue 1, 2011, Pages

  Rappuoli, Rino ^a  

^a NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; BACTERIAL ANTIGEN; CAPSULAR POLYSACCHARIDE; CD4 ANTIGEN; CROSS REACTING MATERIAL 197 LAMINARIN CONJUGATE VACCINE; FACTOR H BINDING PROTEIN; FUNGUS VACCINE; GLYCOPROTEIN GP 120; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INFLUENZA VACCINE; MENINGOCOCCUS VACCINE; MIFAMURTIDE; MONOCLONAL ANTIBODY 2G8; NEISSERIA HEPARIN BINDING ANTIGEN; NEISSERIA MENINGITIDIS ADHESIN A; NEUTRALIZING ANTIBODY; PLASMID DNA; POLYSACCHARIDE; PORIN A; UNCLASSIFIED DRUG; UNIVERSAL VACCINE; VACCINE; VIRUS HEMAGGLUTININ;

2009 H1N1 INFLUENZA; ANTIBODY AFFINITY; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIFUNGAL ACTIVITY; ASPERGILLOSIS; BACTERIAL GENOME; BACTERIAL STRAIN; BINDING SITE; CANDIDIASIS; CROSS REACTION; CRYPTOCOCCOSIS; CRYSTAL STRUCTURE; DRUG CONJUGATION; EPIDEMIC MENINGITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGENICITY; INFLUENZA A (H5N1); INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H5N1; MEMORY CELL; MEMORY T LYMPHOCYTE; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; NONHUMAN; REVIEW; VACCINE PRODUCTION; VIRUS NEUTRALIZATION;

EID: 80052209338     PISSN: None     EISSN: 17575931     Source Type: Journal    
DOI: 10.3410/M3-16     Document Type: Review

References (16)

1. Costantino P, Viti S, Podda A, Velmonte MA, Nencioni L, Rappuoli R: Development and phase 1 clinical testing of a conjugate vaccine against meningococcus A and C. Vaccine 1992, 10:691-8.
2. Tondella ML, Popovic T, Rosenstein NE, Lake DB, Carlone GM, Mayer LW, Perkins BA: Distribution of Neisseria meningitidis serogroup B serosubtypes and serotypes circulating in the United States. The Active Bacterial Core Surveillance Team. J Clin Microbiol 2000, 38:3323-8.
3. Pizza M, Scarlato V, Masignani V, Giuliani MM, Aricò B, Comanducci M, Jennings GT, Baldi L, Bartolini E, Capecchi B, Galeotti CL, Luzzi E, Manetti R, Marchetti E, Mora M, Nuti S, Ratti G, Santini L, Savino S, Scarselli M, Storni E, Zuo P, Broeker M, Hundt E, Knapp B, Blair E, Mason T, Tettelin H, Hood DW, Jeffries AC, et al.: Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 2000, 287:1816-20.
4. Giuliani MM, Adu-Bobie J, Comanducci M, Aricò B, Savino S, Santini L, Brunelli B, Bambini S, Biolchi A, Capecchi B, Cartocci E, Ciucchi L, Di Marcello F, Ferlicca F, Galli B, Luzzi E, Masignani V, Serruto D, Veggi D, Contorni M, Morandi M, Bartalesi A, Cinotti V, Mannucci D, Titta F, Ovidi E, Welsch JA, Granoff D, Rappuoli R, Pizza M: A universal vaccine for serogroup B meningococcus. Proc Natl Acad Sci U S A 2006, 103:10834-9. (Pubitemid 44148381)
5. Donnelly J, Medini D, Boccadifuoco G, Biolchi A, Ward J, Frasch C, Moxon ER, Stella M, Comanducci M, Bambini S, Muzzi A, Andrews W, Chen J, Santos G, Santini L, Boucher P, Serruto D, Pizza M, Rappuoli R, Giuliani MM: Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines. Proc Natl Acad Sci U S A 2010, 107:19490-5.
6. Galli G, Medini D, Borgogni E, Zedda L, Bardelli M, Malzone C, Nuti S, Tavarini S, Sammicheli C, Hilbert AK, Brauer V, Banzhoff A, Rappuoli R, Del Giudice G, Castellino F: Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels. Proc Natl Acad Sci U S A 2009, 106:3877-82.
7. Khurana S, Chearwae W, Castellino F, Manischewitz J, King LR, Honorkiewicz A, Rock MT, Edwards KM, Del Giudice G, Rappuoli R, Golding H: Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus. Sci Transl Med 2010, 2:15ra5.
8. Neirynck S, Deroo T, Saelens X, Vanlandschoot P, Jou WM, Fiers W: A universal influenza A vaccine based on the extracellular domain of the M2 protein. Nat Med 1999, 10:1119-20.
9. Ekiert DC, Bhabha G, Elsliger MA, Friesen RH, Jongeneelen M, Throsby M, Goudsmit J,Wilson IA: Antibody recognition of a highly conserved influenza virus epitope. Science 2009, 324:246-51.
10. Wei CJ, Boyington JC, McTamney PM, Kong WP, Pearce MB, Xu L, Andersen H, Rao S, Tumpey TM, Yang ZY, Nabel GJ: Induction of broadly neutralizing H1N1 influenza antibodies by vaccination. Science 2010, 329:1060-4.
11. Kwong PD, Wilson IA: HIV-1 and influenza antibodies: seeing antigens in new ways. Nat Immunol 2009, 10:573-8.
12. Wu X, Yang ZY, Li Y, Hogerkorp CM, Schief WR, Seaman MS, Zhou T, Schmidt SD, Wu L, Xu L, Longo NS, McKee K, O'Dell S, Louder MK, Wycuff DL, Feng Y, Nason M, Doria-Rose N, Connors M, Kwong PD, Roederer M, Wyatt RT, Nabel GJ, Mascola JR: Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1. Science 2010, 329:856-61.
13. Zhou T, Georgiev I, Wu X, Yang ZY, Dai K, Finzi A, Kwon YD, Scheid JF, Shi W, Xu L, Yang Y, Zhu J, Nussenzweig MC, Sodroski J, Shapiro L, Nabel GJ, Mascola JR, Kwong PD: Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01. Science 2010, 329:811-7.
14. Zhou T, Xu L, Dey B, Hessell AJ, Van Ryk D, Xiang SH, Yang X, Zhang MY, Zwick MB, Arthos J, Burton DR, Dimitrov DS, Sodroski J, Wyatt R, Nabel GJ, Kwong PD: Structural definition of a conserved neutralization epitope on HIV-1 gp120. Nature 2007, 445:732-7. (Pubitemid 46279718)
15. Torosantucci A, Chiani P, Bromuro C, De Bernardis F, Palma AS, Liu Y, Mignogna G, Maras B, Colone M, Stringaro A, Zamboni S, Feizi T, Cassone A: Protection by anti-beta-glucan antibodies is associated with restricted beta-1,3 glucan binding specificity and inhibition of fungal growth and adherence. PLoS One 2009, 4:e5392.
16. Pietrella D, Rachini A, Torosantucci A, Chiani P, Brown AJ, Bistoni F, Costantino P, Mosci P, d'Enfert C, Rappuoli R, Cassone A, Vecchiarelli A: A beta-glucan-conjugate vaccine and anti-beta-glucan antibodies are effective against murine vaginal candidiasis as assessed by a novel in vivo imaging technique. Vaccine 2010, 28:1717-25.